Figure 7
Figure 7. Tregs derived from different tissues of healthy human donors migrate to different chemokines. Flow cytometry of homing marker expression and migratory capacity of CD4posCD25posCD127negCD69pos Tregs and CD4posCD25posCD127negCD69neg in human SPL and PB samples. (A) Percentages of Tregs positive for indicated markers are shown (N = 3 for each tissue). Data were analyzed using a random effect logistic regression model. Significant differences are indicated: *P < .05; **P < .01; ***P < .001. (B) Migration assays were performed using a transwell system, with the indicated recombinant human chemokines present in the lower compartment. The migratory capacity of the Treg subsets is shown (mean plus SD, N = 3 for each tissue). Data were compared using 1-way ANOVA. Significant differences are indicated: *P < .05; **P < .01; ***P < .001.

Tregs derived from different tissues of healthy human donors migrate to different chemokines. Flow cytometry of homing marker expression and migratory capacity of CD4posCD25posCD127negCD69pos Tregs and CD4posCD25posCD127negCD69neg in human SPL and PB samples. (A) Percentages of Tregs positive for indicated markers are shown (N = 3 for each tissue). Data were analyzed using a random effect logistic regression model. Significant differences are indicated: *P < .05; **P < .01; ***P < .001. (B) Migration assays were performed using a transwell system, with the indicated recombinant human chemokines present in the lower compartment. The migratory capacity of the Treg subsets is shown (mean plus SD, N = 3 for each tissue). Data were compared using 1-way ANOVA. Significant differences are indicated: *P < .05; **P < .01; ***P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal